As of 2025-07-05, the Relative Valuation of Citius Pharmaceuticals Inc (CTXR) is (99.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.21 USD, the upside of Citius Pharmaceuticals Inc based on Relative Valuation is -4596.8%.
The range of the Relative Valuation is (98.97) - (95.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 18.5x | 18.0x |
| Forward P/E multiples | 19.2x - 22.3x | 20.6x |
| Fair Price | (98.97) - (95.05) | (99.38) |
| Upside | -4578.2% - -4401.1% | -4596.8% |
| Date | P/E |
| 2025-07-03 | -0.43 |
| 2025-07-02 | -0.41 |
| 2025-07-01 | -0.37 |
| 2025-06-30 | -0.31 |
| 2025-06-27 | -0.30 |
| 2025-06-26 | -0.26 |
| 2025-06-25 | -0.23 |
| 2025-06-24 | -0.25 |
| 2025-06-23 | -0.20 |
| 2025-06-20 | -0.21 |
| 2025-06-18 | -0.18 |
| 2025-06-17 | -0.17 |
| 2025-06-16 | -0.15 |
| 2025-06-13 | -0.17 |
| 2025-06-12 | -0.18 |
| 2025-06-11 | -0.20 |
| 2025-06-10 | -0.21 |
| 2025-06-09 | -0.27 |
| 2025-06-06 | -0.17 |
| 2025-06-05 | -0.17 |
| 2025-06-04 | -0.17 |
| 2025-06-03 | -0.17 |
| 2025-06-02 | -0.15 |
| 2025-05-30 | -0.13 |
| 2025-05-29 | -0.14 |
| 2025-05-28 | -0.14 |
| 2025-05-27 | -0.14 |
| 2025-05-23 | -0.14 |
| 2025-05-22 | -0.14 |
| 2025-05-21 | -0.13 |
| 2025-05-20 | -0.14 |
| 2025-05-19 | -0.15 |
| 2025-05-16 | -0.16 |
| 2025-05-15 | -0.16 |
| 2025-05-14 | -0.18 |
| 2025-05-13 | -0.15 |
| 2025-05-12 | -0.15 |
| 2025-05-09 | -0.15 |
| 2025-05-08 | -0.14 |
| 2025-05-07 | -0.14 |
| 2025-05-06 | -0.14 |
| 2025-05-05 | -0.16 |
| 2025-05-02 | -0.15 |
| 2025-05-01 | -0.14 |
| 2025-04-30 | -0.15 |
| 2025-04-29 | -0.15 |
| 2025-04-28 | -0.16 |
| 2025-04-25 | -0.16 |
| 2025-04-24 | -0.17 |
| 2025-04-23 | -0.16 |